Librarian View

LEADER 05486cam a2200625 i 4500
001 16157060
005 20220304173300.0
006 m o d
007 cr cnu---unuuu
008 211120s2022 ne o 000 0 eng d
020
  
  
|a 0128226714 |q (electronic book)
020
  
  
|a 9780128226711 |q (electronic bk.)
020
  
  
|z 0128194693
020
  
  
|z 9780128194690
024
  
  
|a 302578721
035
  
  
|a (NhCcYBP)ybp302578721
035
  
  
|a 16157060
040
  
  
|a NhCcYBP |b eng |c NhCcYBP
050
  
4
|a R857.M3 |b N35 2022
079
  
  
|a 1285779191
090
  
  
|a R857.M3 |b N35 2022 (LC)
245
0
0
|a Nanotechnology in Medicine and Biology |h [electronic resource] / |c edited by Huinan H. Liu, Tolou Shokuhfar, Sougata Ghosh.
264
  
1
|a Amsterdam, Netherlands ; |a Oxford, United Kingdom ; |a Cambridge, MA : |b Elsevier, |c [2022]
300
  
  
|a 1 online resource ( 296 pages).
336
  
  
|a text |b txt |2 rdacontent
337
  
  
|a computer |b c |2 rdamedia
338
  
  
|a online resource |b cr |2 rdacarrier
490
0
  
|a Elsevier Series on Advanced Topics in Biomaterials
505
0
  
|a Intro -- Nanotechnology in Medicine and Biology -- Copyright -- Contents -- Contributors -- Preface -- Chapter 1 Nanobiomaterials for three-dimensional bioprinting -- 1.1 Introduction -- 1.2 Inkjet bioprinting -- 1.3 Bioplotting -- 1.4 Fused-deposition modeling -- 1.5 Selective laser sintering -- 1.6 Stereolithography -- 1.7 3D printing for complex tissue and organ regeneration -- 1.7.1 Bone -- 1.7.2 Cartilage and osteochondral tissue -- 1.7.3 Neural tissue -- 1.7.4 Vascular tissue -- 1.7.5 Organs -- 1.8 4D printing -- 1.9 Conclusion and future perspectives -- Acknowledgments
504
  
  
|a References-Chapter 2 Nanobiomaterials for drug delivery and theranostics-2.1 Introduction-2.2 Design parameters of nanomedicine for drug delivery and theranostics-2.3 Targeted drug delivery for cancer therapy-2.3.1 Passive targeting-2.3.2 Active targeting-2.3.2.1 Tumor cell targeting-2.3.2.2 Vascular targeting (anti-angiogenesis)-2.4 Toxicity of nanobiomaterials-2.5 Biodegradable nanomaterials used in controlled drug delivery and imaging-2.5.1 Organic and polymer-based nanocarriers-2.5.1.1 Liposomes-2.5.1.2 Biodegradable polymer-based nanocarriers.
505
8
  
|a 2.5.1.3 Dendrimers -- 2.5.2 Inorganic nanobiomaterials for drug delivery and imaging -- 2.5.2.1 Carbon-based nanomaterials -- i) Fullerenes -- ii) Carbon nanotubes -- iii) Graphene and graphene oxide -- 2.5.2.2 Gold nanoparticles -- 2.5.2.3 Magnetic nanoparticles -- 2.5.2.4 Quantum dots -- 2.5.2.5 Mesoporous silica nanoparticles -- 2.6 Conclusion and future perspectives -- References -- Chapter 3 Nanobiomaterials in hard tissue repair -- 3.1 Introduction -- 3.2 Biomaterials in hard tissue engineering -- 3.2.1 Problems in biomaterials -- 3.2.2 Why nanobiomaterials are a potential solution?
505
8
  
|a 3.3 Nanobiomaterials in tissue engineering -- 3.3.1 Polymeric nanobiomaterials -- 3.3.1.1 Polymers of natural origin -- 3.3.1.2 Synthetic polymers -- 3.3.2 Ceramic nanobiomaterials -- 3.3.2.1 Bioceramics -- 3.3.2.2 Bioglass: Bioactive ceramic materials -- 3.3.3 Metallic nanobiomaterials -- 3.3.4 Nanobiomaterials from carbon -- 3.3.5 Nanobiomaterial composites -- 3.4 Role of stem cells -- 3.5 Conclusion and future perspectives -- References -- Chapter 4 Application of nanobiomaterials in soft tissue engineering -- 4.1 Introduction -- 4.2 Tissue engineering
505
8
  
|a 4.2.1 Nanotechnology in scaffold designing -- 4.2.2 Nanobiomaterials in soft tissue regeneration -- 4.3 Nanobiomaterials in cartilage tissue engineering -- 4.3.1 Cartilage tissue -- 4.3.2 Rationale for cartilage tissue engineering -- 4.3.3 Cartilage tissue engineering -- 4.3.4 Nanobiomaterials in cartilage tissue engineering -- 4.3.4.1 Nanofibers in cartilage tissue engineering -- 4.3.4.2 Nanocomposites in cartilage tissue engineering -- 4.4 Nanobiomaterials in tendon/ligament tissue engineering -- 4.4.1 Tendon/ligament tissue -- 4.4.2 Rationale for tendon/ligament tissue engineering
500
  
  
|a 4.4.3 Nanobiomaterials in tendon/ligament tissue engineering.
506
  
  
|a Access restricted by licensing agreement.
533
  
  
|a Electronic reproduction. |b Amsterdam |n Available via World Wide Web.
588
0
  
|a Online resource; title from digital title page (viewed on December 30, 2021).
590
  
  
|a Access is available to the Yale community.
650
  
0
|a Biomedical materials |x Technological innovations.
700
1
  
|a Liu, Huinan, |e editor. |0 http://id.loc.gov/authorities/names/no2014122657
700
1
  
|a Shokuhfar, Tolou, |e editor.
700
1
  
|a Ghosh, Sougata, |e editor. |0 http://id.loc.gov/authorities/names/n2015071385
710
2
  
|a ScienceDirect (Online service) |0 http://id.loc.gov/authorities/names/no00037061
776
0
8
|i Print version: |a Liu, Huinan. |t Nanotechnology in Medicine and Biology. |d San Diego : Elsevier, ©2021 |z 9780128194690
852
8
0
|z Online resource
856
4
0
|y Online book |u https://yale.idm.oclc.org/login?URL=https://www.sciencedirect.com/science/book/9780128194690
901
  
  
|a R857.M3
902
  
  
|a Yale Internet Resource |b Yale Internet Resource >> None|DELIM|16089211
905
  
  
|a online resource
907
  
  
|a 2022-03-15T15:39:59.000Z
946
  
  
|a DO NOT EDIT. DO NOT EXPORT.
953
  
  
|a https://www.sciencedirect.com/science/book/9780128194690
960
  
  
|o 1 |s 188.00 |t yulintx |u YBSSENG251
961
  
  
|c 220223 |f 201335 |m 653155
987
  
  
|a 302578721 |c None |d Online resource